Bronchodilator action of drug combinations in asthmatic patients: decloxizine, orciprenaline, and ephedrine.
D000336:Aerosols; D001249:Asthma / Q000188:drug therapy*; D001993:Bronchodilator Agents / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004357:Drug Synergism; D004809:Ephedrine / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D006919:Hydroxyzine / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D007275:Injections, Intravenous; D009921:Metaproterenol / Q000008:administration & dosage / Q000627:therapeutic use; D010627:Phenethylamines / Q000627:therapeutic use*; D010919:Placebos; D012118:Resorcinols / Q000627:therapeutic use*; D013607:Tablets
D000336:Aerosols; D001993:Bronchodilator Agents; D010627:Phenethylamines; D010919:Placebos; D012118:Resorcinols; D013607:Tablets; D006919:Hydroxyzine; D009921:Metaproterenol; D004809:Ephedrine